Jessica Bond is an associate attorney with the Plato Law Firm. Her practice focuses on insurance defense, construction litigation and municipal law.
Prior to joining the Plato Law Firm, Ms. Bond worked for a Detroit-area firm specializing in bankruptcy and commercial law matters, and before that with a firm specializing in land use and municipal law matters. While working in municipal law, Ms. Bond contributed to the writing and editing of a book on the Religious Land Use and Institutionalized Persons Act, a statute the municipal firm litigated throughout the U.S. She also previously worked as an intern for the Honorable Kelley R. Kostin, 52-2 District Court and with the Wayne County Prosecutor’s Office. Before law school, she worked with a firm specializing in Michigan no-fault and third-party auto negligence matters.
Jessica Bond graduated magna cum laude from the University of Detroit Mercy School of Law. She served as the Law Review’s Executive Editor of Inside Articles and as a member of the Moot Court Board of Advocates. During this time, she published her law review note, “Some Thoughts in the Wake of U.S. v. Stevens,” 90 U. Det. Mercy L. Rev. 59 (2012) and was a quarterfinalist in the Patrick A. Keenan Memorial Appellate Advocacy Tournament.
As a law student, she achieved book awards for receiving the highest grade in Advanced Advocacy, Corporate Governance, Advising Entrepreneurs in Business, Federal Jurisdiction, Immigration Law Clinic, National Security Law, Payment Systems, and Remedies. She was also inducted into the Frank Murphy Honor Society, for graduating in the top 10% of her class.
She is a Member of the State Bar of Michigan and admitted to practice in the U.S. District Court, Eastern District of Michigan. She regularly engages in civil litigation in her areas of specialization in the Wayne, Oakland and Macomb County Circuit Courts.
Jessica has also been elected to the Board of Directors of Camp Casey, a Michigan nonprofit organization that provides therapeutic horse experiences and programs for children undergoing treatment for cancer, sickle cell disease, and/or aplastic anemia.